SCHEMBL6880927

SCHEMBL6880927

O=CC#Cc1ccc(-c2ncccn2)s1

nearest known ligand 0.41

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.41
KDM4E B2RXH2 1/20 0.32
NPC1 O15118 1/20 0.32
GLA P06280 1/20 0.32
MAPT P10636 1/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6851761 0.84 KDM4E (0.55) HDAC1KDM4ENPC1GLAMAPT
SCHEMBL3900804 0.77 HDAC1 (0.41) HDAC1KDM4ENPC1GLAMAPT
SCHEMBL6854124 0.77 HDAC3 (0.41) HDAC1KDM4EMAPT
SCHEMBL6852026 0.76 KDM4E (0.33) KDM4ENPC1GLAMAPTRAB9A
SCHEMBL6847768 0.76 CYP2A6 (0.56) HDAC1
SCHEMBL6850474 0.76 HSP90AA1 (0.32) KDM4ENPC1GLAMAPTRAB9A
SCHEMBL3904118 0.73 HDAC1 (0.38) HDAC1KDM4ENPC1GLAMAPT
SCHEMBL6854322 0.73 HDAC1 (0.41) HDAC1KDM4ENPC1GLAMAPT
SCHEMBL6852255 0.72 CYP2A6 (0.37)
SCHEMBL13722910 0.70 HDAC1 (0.36) HDAC1KDM4ENPC1GLAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1585775-A 6-O-acyl ketolide derivatives of erythromycine useful as antibacterials ORTHO MCNEIL PHARM INC (US) 2005-02-23 CN disclosed
US-6825170-B2 ERYTHROMYCIN TYPE MACROLIDE WITH A FUSED OXAZOLONE RING ORTHO-MCNEIL PHARMACEUTICAL, INC. 2004-11-30 US disclosed
EP-1453847-A1 6-O-ACYL KETOLIDE DERIVATIVES OF ERYTHROMYCINE USEFUL AS ANTIBACTERIALS Ortho-Mcneil Pharmaceutical, Inc. (US) 2004-09-08 EP disclosed
WO-2003050132-A1 6-O-ACYL KETOLIDE DERIVATIVES OF ERYTHROMYCINE USEFUL AS ANTIBACTERIALS ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2003-06-19 WO disclosed